260 related articles for article (PubMed ID: 35953726)
1. Phenotypic and genetic classification of diabetes.
Deutsch AJ; Ahlqvist E; Udler MS
Diabetologia; 2022 Nov; 65(11):1758-1769. PubMed ID: 35953726
[TBL] [Abstract][Full Text] [Related]
2. Diabetes precision medicine: plenty of potential, pitfalls and perils but not yet ready for prime time.
Griffin S
Diabetologia; 2022 Nov; 65(11):1913-1921. PubMed ID: 35999379
[TBL] [Abstract][Full Text] [Related]
3. Type 2 Diabetes: Multiple Genes, Multiple Diseases.
Udler MS
Curr Diab Rep; 2019 Jul; 19(8):55. PubMed ID: 31292748
[TBL] [Abstract][Full Text] [Related]
4. Monogenic Diabetes: Genetics and Relevance on Diabetes Mellitus Personalized Medicine.
Sousa M; Bruges-Armas J
Curr Diabetes Rev; 2020; 16(8):807-819. PubMed ID: 31886753
[TBL] [Abstract][Full Text] [Related]
5. Precision diabetes: learning from monogenic diabetes.
Hattersley AT; Patel KA
Diabetologia; 2017 May; 60(5):769-777. PubMed ID: 28314945
[TBL] [Abstract][Full Text] [Related]
6. How Recent Advances in Genomics Improve Precision Diagnosis and Personalized Care of Maturity-Onset Diabetes of the Young.
Vaxillaire M; Froguel P; Bonnefond A
Curr Diab Rep; 2019 Aug; 19(9):79. PubMed ID: 31385057
[TBL] [Abstract][Full Text] [Related]
7. Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis.
Udler MS; Kim J; von Grotthuss M; Bonàs-Guarch S; Cole JB; Chiou J; ; Boehnke M; Laakso M; Atzmon G; Glaser B; Mercader JM; Gaulton K; Flannick J; Getz G; Florez JC
PLoS Med; 2018 Sep; 15(9):e1002654. PubMed ID: 30240442
[TBL] [Abstract][Full Text] [Related]
8. Future Roadmaps for Precision Medicine Applied to Diabetes: Rising to the Challenge of Heterogeneity.
Bowman P; Flanagan SE; Hattersley AT
J Diabetes Res; 2018; 2018():3061620. PubMed ID: 30599002
[TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics in type 2 diabetes: precision medicine or discovery tool?
Florez JC
Diabetologia; 2017 May; 60(5):800-807. PubMed ID: 28283684
[TBL] [Abstract][Full Text] [Related]
10. Precision medicine in the management of type 2 diabetes.
Gloyn AL; Drucker DJ
Lancet Diabetes Endocrinol; 2018 Nov; 6(11):891-900. PubMed ID: 29699867
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine in type 2 diabetes.
Prasad RB; Groop L
J Intern Med; 2019 Jan; 285(1):40-48. PubMed ID: 30403316
[TBL] [Abstract][Full Text] [Related]
12. Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: what we know and what we need to know.
Smith RJ; Nathan DM; Arslanian SA; Groop L; Rizza RA; Rotter JI
J Clin Endocrinol Metab; 2010 Apr; 95(4):1566-74. PubMed ID: 20194712
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of a self-management intervention with personalised genetic and lifestyle-related risk information on coronary heart disease and diabetes-related risk in type 2 diabetes (CoRDia): study protocol for a randomised controlled trial.
Davies AK; McGale N; Humphries SE; Hirani SP; Beaney KE; Bappa DA; McCabe JG; Newman SP
Trials; 2015 Dec; 16():547. PubMed ID: 26631181
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic and Genetic Heterogeneity in a Thai Glucokinase MODY Family Reveals the Complexity of Young-Onset Diabetes.
Thewjitcharoen Y; Wanothayaroj E; Krittiyawong S; Nakasatien S; Tsoi TF; Lim CKP; Chan JCN; Himathongkam T
Front Endocrinol (Lausanne); 2021; 12():690343. PubMed ID: 34630320
[TBL] [Abstract][Full Text] [Related]
15. Validating and automating learning of cardiometabolic polygenic risk scores from direct-to-consumer genetic and phenotypic data: implications for scaling precision health research.
Lopez-Pineda A; Vernekar M; Moreno-Grau S; Rojas-Muñoz A; Moatamed B; Lee MTM; Nava-Aguilar MA; Gonzalez-Arroyo G; Numakura K; Matsuda Y; Ioannidis A; Katsanis N; Takano T; Bustamante CD
Hum Genomics; 2022 Sep; 16(1):37. PubMed ID: 36076307
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing.
GoodSmith MS; Skandari MR; Huang ES; Naylor RN
Diabetes Care; 2019 Dec; 42(12):2247-2255. PubMed ID: 31558549
[TBL] [Abstract][Full Text] [Related]
17. Atypical Diabetes Presentations in Sub-Saharan Africa Classification Puzzle and Possible Role of Precision Medicine.
Balogun WO; Uloko AE; Owolabi MO
West Afr J Med; 2020 Oct; 37(5):574-582. PubMed ID: 33058135
[TBL] [Abstract][Full Text] [Related]
18. Personalized medicine in diabetes.
Malandrino N; Smith RJ
Clin Chem; 2011 Feb; 57(2):231-40. PubMed ID: 21127150
[TBL] [Abstract][Full Text] [Related]
19. Genetics of Type 2 Diabetes: Opportunities for Precision Medicine: JACC Focus Seminar.
Kim DS; Gloyn AL; Knowles JW
J Am Coll Cardiol; 2021 Aug; 78(5):496-512. PubMed ID: 34325839
[TBL] [Abstract][Full Text] [Related]
20. The clinical consequences of heterogeneity within and between different diabetes types.
Redondo MJ; Hagopian WA; Oram R; Steck AK; Vehik K; Weedon M; Balasubramanyam A; Dabelea D
Diabetologia; 2020 Oct; 63(10):2040-2048. PubMed ID: 32894314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
